Tiger BufordYour Orthopedic Industry Expert (free today)

BoneChat short discussion about the use of stem cells in ortho

16 May 2026 · 1 min

Watch on YouTube

1:26

In this brief monologue, the speaker—who participates in a stem‑cell network out of personal interest—shares his perspective on the current landscape of stem‑cell and PRP (platelet‑rich plasma) therapies in orthopedics. He references a weekly newsletter that published a nationwide survey identifying roughly 75 stem‑cell clinics, primarily clustered in Southern California, Florida, and New York, attributing this pattern to aging demographics, affluent patient bases, and openness to alternative treatments. He recalls Rick Fessler’s STAR study on spinal‑cord injury, noting that the study’s protocol was specifically altered to address the overarching safety gap in stem‑cell applications. The speaker emphasizes the paucity of robust safety data, citing anecdotal adverse events such as ocular injections in Florida that resulted in blindness. He underscores the fundamental scientific challenge: introducing living cells into the body without precise control over their differentiation pathways, and the need to identify appropriate catalysts to steer growth safely.

Chapters

Do you guys have a stance on stem cells, you know, or PRP, those things? You're hitting all my hot buttons. Yeah. I gave a presentation a couple of years ago about— there was— I'm in this kind of stem cell network myself just because it's a personal interest. And I can't remember the guy's name, but there's a newsletter he puts out every, every week. And 2 years ago, maybe 3, he did a study, a nationwide study about the number of stem cell clinics that had popped up. And I think it was something like 75, and they were concentrated in Southern California, Florida, and New York, because you've got aging populations, people who have money, and people are willing to try alternatives. So I remember when Rick Fessler in New York was starting his, um, STAR study with spinal cord injury issues, and I said, you know, Rick, the big problem that stem cells have is nobody's proving safety. So he adjusted his is a protocol to prove safety. Because that's the big problem is there's really little safety data about these procedures and a lot of anecdotes where things went wrong. You know, there's reports of people getting ocular injections in Florida and then ending up blind. And then the worry is you're putting living cells into other parts of the body and you don't know what it's gonna grow into. So trying to figure out what the catalysts are to make it grow the right way, that's really the trickiest part.